Document is current

Any future updates will be listed below

The Efficacy and Safety of Nivolumab Combined with Nab-Paclitaxel or Oxaliplatin as a First-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer

Crossref DOI link: https://doi.org/10.1007/s12029-025-01211-1

Published Online: 2025-04-28

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark